Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
CALL
Invesco CurrencyShares Australian Dollar Trust
FXA
$97.6M
| $338K | ﹤0.01% |
5,000
+4,800
| +2,400% | +$329K |
|
4477
Cullen/Frost Bankers
CFR
$10.5B
| $337K | ﹤0.01% |
3,797
-26,114
| -87% | -$2.31M |
|
4478
CALL
ZTO Express
ZTO
$18.2B
| $337K | ﹤0.01% |
15,800
+2,600
| +20% | +$52.3K |
|
4479
PUT
Lazard
LAZ
$4.26B
| $336K | ﹤0.01% |
9,600
-5,400
| -36% | -$191K |
|
|
AVDR
4480
DELISTED
Avedro, Inc Common Stock
AVDR
| $336K | ﹤0.01% |
14,795
+11,543
| +355% | +$251K |
|
4481
Community Trust Bancorp
CTBI
$1.44B
| $335K | ﹤0.01% |
7,875
-2,470
| -24% | -$101K |
|
4482
Karyopharm Therapeutics
KPTI
$44.4M
| $335K | ﹤0.01% |
2,320
-690
| -23% | -$93.6K |
|
|
DCUE
4483
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
| $335K | ﹤0.01% |
3,172
-71,828
| -96% | -$7.39M |
|
|
ATRS
4484
DELISTED
Antares Pharma, Inc.
ATRS
| $335K | ﹤0.01% |
100,156
-24,115
| -19% | -$79.4K |
|
|
MDCO
4485
CALL
DELISTED
Medicines Co
MDCO
| $335K | ﹤0.01% |
6,700
+4,600
| +219% | +$183K |
|
|
QIWI
4486
DELISTED
QIWI PLC
QIWI
| $334K | ﹤0.01% |
15,234
+11,530
| +311% | +$249K |
|
4487
PUT
Hartford Financial Services
HIG
$38.9B
| $333K | ﹤0.01% |
5,500
-31,500
| -85% | -$1.84M |
|
4488
Expro Ltd
XPRO
$1.88B
| $333K | ﹤0.01% |
11,702
-342,221
| -97% | -$10.4M |
|
|
FIYY
4489
DELISTED
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
| $333K | ﹤0.01% |
3,060
-5,675
| -65% | -$598K |
|
4490
Great Southern Bancorp
GSBC
$893M
| $332K | ﹤0.01% |
5,826
-1,574
| -21% | -$90.9K |
|
|
PRTY
4491
DELISTED
Party City Holdco Inc.
PRTY
| $332K | ﹤0.01% |
58,178
-89,217
| -61% | -$509K |
|
4492
CALL
Commault Systems
CVLT
$5.47B
| $331K | ﹤0.01% |
7,400
+6,400
| +640% | +$293K |
|
4493
PUT
H&R Block
HRB
$5.84B
| $331K | ﹤0.01% |
14,000
-6,300
| -31% | -$167K |
|
4494
CALL
Leggett & Platt
LEG
$1.43B
| $331K | ﹤0.01% |
8,100
+4,000
| +98% | +$157K |
|
|
YMAB
4495
DELISTED
Y-mAbs Therapeutics
YMAB
| $331K | ﹤0.01% |
12,701
-418
| -3% | -$10.7K |
|
|
ZIXI
4496
DELISTED
Zix Corporation
ZIXI
| $330K | ﹤0.01% |
45,583
-3,038
| -6% | -$25.3K |
|
4497
PUT
Direxion Daily Energy Bull 2X ETF
ERX
$225M
| $329K | ﹤0.01% |
2,110
-950
| -31% | -$160K |
|
4498
First Northwest Bancorp
FNWB
$107M
| $329K | ﹤0.01% |
19,000
-2,113
| -10% | -$34.4K |
|
4499
FB Financial Corp
FBK
$3.1B
| $328K | ﹤0.01% |
8,747
-2,225
| -20% | -$82.1K |
|
4500
Horizon Bancorp
HBNC
$1.06B
| $328K | ﹤0.01% |
18,963
-5,890
| -24% | -$98K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.